RxDoctor Payments Data

Lucas Korcek, MD

Orthopaedic Surgery · Eugene, ORNPI 1194083071

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (45.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Steelhead Surgical Inc at 54.7% of the total. Reporting peaked in 2019 at $3,174 and has fallen 91.0% since, to $287 in 2025.

$9,318in general payments, 2019–2025

Across 56 payments — averaging $166.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Steelhead Surgical Inc$5K
  • Arthrex$2K
  • Johnson & Johnson$1K
  • Linvatec Corporation$185
  • Miach Orthopaedics, Inc.$171
  • Anika Therapeutics, Inc.$145
  • plus $682 from 10 others

What the payments were for

  • Travel & lodging$3,37336%
  • Food & beverage$1,73419%
  • Education$4,21145%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,318 in reported general payments places this provider in the 75th percentile of 228 orthopaedic surgery providers in Oregon.

See all orthopaedic surgery providers in Oregon

Medicare billing

Part B allowed, 2024
$210,037
Medicare patients
282
Services billed
2,838

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib378$5,571
Ondansetron OdtOndansetron269$2,825
Oxycodone Hcl132$914
Mupirocin61$541
Tramadol Hcl49$210
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$208
Meloxicam38$177
Cephalexin16$144
Methylprednisolone20$142

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Eugene

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →